What Can We Do to Optimize Colonoscopy and How Effective Can We Be?
In the USA, colorectal cancer is the third most common cancer and third leading cause of cancer death among both men and women. Declining rates of colon cancer in the past decade have been attributed in part to screening and removal of precancerous polyps via colonoscopy. Recent emphasis has been placed on measures to increase the quality and effectiveness of colonoscopy. These have been divided into pre-procedure quality metrics (bowel preparation), procedural quality metrics (cecal intubation, withdrawal time, and adenoma detection rate), post-procedure metrics (surveillance interval), and other quality metrics (patient satisfaction and willingness to repeat the procedure). The purpose of this article is to review the data and controversies surrounding each of these and identify ways to optimize the performance of colonoscopy.
Central Texas Veterans Health Care System, 7901 Metropolis Drive, Austin, TX, 78744, USA.
Kelli S
KS
Hancock
Central Texas Veterans Health Care System, 7901 Metropolis Drive, Austin, TX, 78744, USA.
Ranjan
R
Mascarenhas
Division of Gastroenterology and Hepatology, Oregon Health & Science University, Portland VA Medical Center, 3710 SW U.S. Veterans Hospital Rd., P3-GI, Portland, OR, 97239, USA. lieberma@ohsu.edu.
David
D
Lieberman
D000236:Adenoma / Q000175:diagnosis*; D002400:Cathartics / Q000008:administration & dosage; D002432:Cecum / Q000473:pathology; D003113:Colonoscopy / Q000379:methods* / Q000592:standards* / Q000639:trends; D015179:Colorectal Neoplasms / Q000175:diagnosis*; D055088:Early Detection of Cancer / Q000379:methods; D006801:Humans; D017060:Patient Satisfaction; D011230:Precancerous Conditions / Q000175:diagnosis
D002400:Cathartics
Adenoma detection rate; Bowel prep; Colonoscopy